OpenURL Connection Search

Select item for more details and to access through your institution.

Reprogramming of the FOXA1 cistrome in treatment-emergent neuroendocrine prostate cancer.
Published in:
Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-22139-7
By:
- Baca, Sylvan C.;
- Takeda, David Y.;
- Seo, Ji-Heui;
- Hwang, Justin;
- Ku, Sheng Yu;
- Arafeh, Rand;
- Arnoff, Taylor;
- Agarwal, Supreet;
- Bell, Connor;
- O'Connor, Edward;
- Qiu, Xintao;
- Alaiwi, Sarah Abou;
- Corona, Rosario I.;
- Fonseca, Marcos A. S.;
- Giambartolomei, Claudia;
- Cejas, Paloma;
- Lim, Klothilda;
- He, Monica;
- Sheahan, Anjali;
- Nassar, Amin
Publication type:
Article
NOTCH3 Is a Prognostic Factor That Promotes Glioma Cell Proliferation, Migration and Invasion via Activation of CCND1 and EGFR.
Published in:
PLoS ONE, 2013, v. 8, n. 10, p. 1, doi. 10.1371/journal.pone.0077299
By:
- Alqudah, Mohammad A. Y.;
- Agarwal, Supreet;
- Al-Keilani, Maha S.;
- Sibenaller, Zita A.;
- Ryken, Timothy C.;
- Assem, Mahfoud
Publication type:
Article
Tumor Derived Mutations of Protein Tyrosine Phosphatase Receptor Type K Affect Its Function and Alter Sensitivity to Chemotherapeutics in Glioma
Published in:
PLoS ONE, 2013, v. 8, n. 5, p. 1, doi. 10.1371/journal.pone.0062852
By:
- Agarwal, Supreet;
- Al-Keilani, Maha S.;
- Alqudah, Mohammad A. Y.;
- Sibenaller, Zita A.;
- Ryken, Timothy C.;
- Assem, Mahfoud
Publication type:
Article
Stem cell dynamics and cellular heterogeneity across lineage subtypes of castrate-resistant prostate cancer.
Published in:
Stem Cells, 2024, v. 42, n. 6, p. 526, doi. 10.1093/stmcls/sxae025
By:
- Beshiri, Michael L;
- Capaldo, Brian J;
- Lake, Ross;
- Ku, Anson T;
- Burner, Danielle;
- Tice, Caitlin M;
- Tran, Crystal;
- Kostas, Julianna;
- Alilin, Aian Neil;
- Yin, JuanJuan;
- Agarwal, Supreet;
- Morris, Samantha A;
- Karzai, Fatima H;
- Lotan, Tamara L;
- Dahut, William L;
- Sowalsky, Adam G;
- Kelly, Kathleen
Publication type:
Article

Found: 4

Reprogramming of the FOXA1 cistrome in treatment-emergent neuroendocrine prostate cancer.

NOTCH3 Is a Prognostic Factor That Promotes Glioma Cell Proliferation, Migration and Invasion via Activation of CCND1 and EGFR.

Tumor Derived Mutations of Protein Tyrosine Phosphatase Receptor Type K Affect Its Function and Alter Sensitivity to Chemotherapeutics in Glioma

Stem cell dynamics and cellular heterogeneity across lineage subtypes of castrate-resistant prostate cancer.